SCHEMBL8553333

SCHEMBL8553333

Nc1cccc2oc3c(=O)c(=O)c3c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
MAOA P21397 7/20 0.41
EGFR P00533 1/20 0.41
ALDH1A1 P00352 4/20 0.37
NQO1 P15559 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
POLB P06746 1/20 0.36
KDM5A P29375 1/20 0.36
JAK2 O60674 1/20 0.35
RPS6KA3 P51812 1/20 0.35
MELK Q14680 1/20 0.35
STK24 Q9Y6E0 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35
CSNK2A3 Q8NEV1 1/20 0.35
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3872856 0.78 ALDH1A1 (0.43) ESR1ESR2MAOAALDH1A1NQO1
SCHEMBL6354852 0.71 MAOA (0.63) MAOAALDH1A1NQO1SMN1; SMN2KDM5A
SCHEMBL10756036 0.69 CYP3A4 (0.41) ESR1ESR2MAOAEGFRALDH1A1
SCHEMBL3383138 0.69 MAOA (0.64) MAOAEGFRALDH1A1NQO1SMN1; SMN2
SCHEMBL19142155 0.67 CD44 (0.48) ESR1ESR2ALDH1A1KDM4ECYP3A4
SCHEMBL3884406 0.67 MAOA (0.48) ESR1ESR2MAOAEGFRALDH1A1
SCHEMBL6650775 0.67 ALDH1A1 (0.53) ALDH1A1NQO1SMN1; SMN2POLBKDM4E
SCHEMBL28390041 0.67 POLB (0.43) ESR1ESR2ALDH1A1NQO1SMN1; SMN2
SCHEMBL31472745 0.66 CA1 (0.66) ESR1ESR2ALDH1A1SMN1; SMN2KDM4E
SCHEMBL8629831 0.66 KDM4E (0.54) ESR1ESR2MAOAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0685474-B1 Oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1998-09-16 EP claimed
US-5565488-A ANTIINFLAMMATORY AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1996-10-15 US claimed
EP-0685474-A1 Oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1995-12-06 EP claimed
EP-0685474-B1 Oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1998-09-16 EP disclosed
EP-0685474-B1 Oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1998-09-16 EP disclosed
US-5565488-A ANTIINFLAMMATORY AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1996-10-15 US disclosed
US-5565488-A ANTIINFLAMMATORY AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1996-10-15 US disclosed
US-5565488-A ANTIINFLAMMATORY AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1996-10-15 US disclosed
CN-1119187-A oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1996-03-27 CN disclosed
CN-1119187-A oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1996-03-27 CN disclosed
EP-0685474-A1 Oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1995-12-06 EP disclosed
EP-0685474-A1 Oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1995-12-06 EP disclosed
EP-0685474-A1 Oxalylamino-benzofuran- and benzothienyl-derivatives BAYER AG (DE) 1995-12-06 EP disclosed